New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Intellia Therapeutics, Inc. (NTLA) vs Nuvation Bio Inc. (NUVB)
- Intellia Therapeutics, Inc. NTLA 10.17 +6.49%
- Nuvation Bio Inc. NUVB 3.78 −0.79%
Intellia Therapeutics, Inc. and Nuvation Bio Inc. are both Biotechnology companies. Intellia Therapeutics, Inc. and Nuvation Bio Inc. are of similar size ($1.4B and $1.3B). Nuvation Bio Inc. grew revenue faster over the last twelve months: 654.2% against −8.07%. Nuvation Bio Inc. has the higher net margin (−67.4% vs −805.8%) and the higher return on invested capital (0.00% vs −195.3%). Across the 17 metrics below, Nuvation Bio Inc. leads on 13 and Intellia Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | NTLA | NUVB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.79% | 70.18% |
| Operating margin | (821.24%) | (61.17%) | 0.00% |
| Net margin | (805.75%) | (67.38%) | 0.00% |
| Free cash flow margin | (676.38%) | (53.62%) | 0.00% |
| Return on equity | (62.60%) | (49.09%) | (51.58%) |
| Return on assets | (46.63%) | (19.70%) | (45.91%) |
| Return on invested capital | (195.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack